Mark K. Slifka - Concepedia

Author

Mark K. Slifka

Oregon Health & Science University ORCID

Also Known As

Amanna, Ian J, Christina Egan, M K Slifka, M SLIFKA, M. K. Slifka, M. Slifka, M.K. Slifka, MARK K. SLIFKA, Mark K Slifka, Mark K. Slifka

206

Publications

15.3K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Oregon National Primate Research Center Children's Cancer Therapy Development Institute Najít Technologies (United States)Scripps Research Institute

About

Mark K. Slifka is an author at Oregon Health & Science University specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	49	6.8K
2	Cell Biology	14	14	2.1K
3	Allergy	7	7	519
4	Health Sciences	1	1	510
5	Biomedical Engineering	1	1	101

Mark K. Slifka

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Duration of Humoral Immunity to Common Viral and Vaccine Antigens Ian J. Amanna, Nichole E. Carlson, Mark K. Slifka New England Journal of Medicine	2007	1.3K
Humoral Immunity Due to Long-Lived Plasma Cells Mark K. Slifka, Rustom Antia, Jason K. Whitmire, Immunity Autoimmune DiseaseHumoral ResponseImmunologyAutoimmunityHumoral Immunity	1998	1.2K
Duration of antiviral immunity after smallpox vaccination Erika Hammarlund, Matthew W. Lewis, Scott G. Hansen, Nature Medicine VaccinationVaccine DevelopmentImmunologyMedicineSmallpox Vaccination	2003	929
Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone Marrow Jessica L. Halliley, Christopher M. Tipton, Jane L. Liesveld, Immunity Human CellMedicineImmunologyHematologyBlood Cell	2015	510
Bone marrow is a major site of long-term antibody production after acute viral infection Mark K. Slifka, Mehrdad Matloubian, Rafi Ahmed Journal of Virology Humoral ResponseViral PathogenesisImmunologyPathologyLcmv-specific Antibody	1995	391
Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox Erika Hammarlund, Matthew W. Lewis, Shirley V. Carter, Nature Medicine VaccinationVaccine DevelopmentVaccine ResearchVaccine TargetVaccine Surveillance	2005	345
Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR Mark K. Slifka, J. Lindsay Whitton Nature Immunology MedicineT-regulatory CellImmunologyAntigen ProcessingAutoimmunity	2001	343
Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections Iuliia M. Gilchuk, Pavlo Gilchuk, Gopal Sapparapu, Cell VaccinationVaccine TargetImmunologyVirologyAntibody Engineering	2016	257
Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells Mark K. Slifka, Fernando Rodrı́guez, J. Lindsay Whitton Nature T-regulatory CellImmunologyVirologyAutoimmunityT Cell Immunity	1999	251
NK Markers Are Expressed on a High Percentage of Virus-Specific CD8+ and CD4+ T Cells Mark K. Slifka, Robb R. Pagarigan, J. Lindsay Whitton The Journal of Immunology	2000	241

Page 1